Background Persistent infection with high‐risk human papillomaviruses (hrHPV) types is
causally linked with the development of cervical precancer and cancer. HPV types 16 and …

Cancer is predicted to be an increasingly important cause of morbidity and mortality in
Bangladesh in the next few decades. The estimated incidence of 12.7 million new cancer …

Background Understanding the safety of vaccines is critical to inform decisions about
vaccination. Our objective was to conduct a systematic review of the safety of vaccines …

Vaccination to prevent human papillomavirus (HPV)-related infection leading to cancer,
particularly cervical cancer, is a major public health breakthrough. There are currently two …

Background The human papillomavirus (HPV) vaccines have been widely introduced in
immunization programs worldwide, however, it is not accepted in mainland China. We …

Introduction: Between 2006 and 2009, two different human papillomavirus virus (HPV)
vaccines were licensed for use: a quadrivalent (qHPVv) and a bivalent (bHPVv) vaccine …

Recently, many studies have evaluated HPV vaccine safety and adverse effects. Two
vaccine shave been recently evaluated in randomized controlled trials: the bivalent vaccine …

As of December 2014, there were 3 approved vaccines for human papillomavirus (HPV):
bivalent Cervarix (GlaxoSmithKline, New York, NY), quadrivalent Gardasil (Merck and Co …

Consecutive cases of human infection with H7N9 influenza viruses since 2013 in China
have prompted efforts to develop an effective treatment. Subunit vaccines introduced by …

Recently, the rate of cancer deaths in less-developed countries such as Bangladesh has
significantly increased day by day, making it a major health issue. The most predominant …